Kraus Carl N 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Kraus Carl N
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-03-07+56,250→ 56,250 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (56,250 underlying) - Award
Common Stock
2024-03-07+112,500→ 262,500 total
Footnotes (2)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment
- [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.